Metraipolis › archive › dc_2991872ac7de

Clinical relevance of CompEx Asthma and impact on disease trajectory: benralizumab effect — Europe PMC PMID:41736726

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41736726
DOI
10.1183/23120541.00486-2025
License (as archived)
solo-consultazione
Archived
2026-11-07T04:24:27.812Z
SHA-256 of the archived text
059d6ce48f271f65ca3684fad219d805cbf8b7c483a8da53713234b0bfcbbb87
Stable URL of this page
https://metraipolis.com/documento/dc_2991872ac7de

How to cite

Clinical relevance of CompEx Asthma and impact on disease trajectory: benralizumab effect — Europe PMC PMID:41736726 — Europe PMC (en), https://europepmc.org/article/MED/41736726 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2991872ac7de (Metraipolis archive dc_2991872ac7de, sha256 059d6ce48f271f65ca3684fad219d805cbf8b7c483a8da53713234b0bfcbbb87)
BibTeX
@misc{dc2991872ac7de,
  title = {Clinical relevance of CompEx Asthma and impact on disease trajectory: benralizumab effect — Europe PMC PMID:41736726},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41736726},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2991872ac7de; sha256 059d6ce48f271f65ca3684fad219d805cbf8b7c483a8da53713234b0bfcbbb87},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41736726. Agents can read the archived copy with the MCP tool read_document.